S1 Biopharma Overview
- Year Founded
-
2008
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$15M
S1 Biopharma General Information
Description
Operator of a biopharmaceutical company intended to develop non-hormonal drugs to treat sexual dysfunction in both women and men. The company develops safe and effective medical approaches designed to treat diminished sexual desire, sexual dysfunction, and hypoactive sexual desire disorder through rigorous clinical trials and non-hormonal therapies, enabling patients to restore the natural balance of neurotransmitters in the brain.
Contact Information
Website
www.s1biopharma.comCorporate Office
- 7 World Trade Center
- 250 Greenwich Street, 46th Floor
- New York, NY 10007
- United States
Corporate Office
- 7 World Trade Center
- 250 Greenwich Street, 46th Floor
- New York, NY 10007
- United States
S1 Biopharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC (Series A) | 01-Mar-2019 | $15M | Completed | Generating Revenue | ||
| 1. IPO | 25-Jun-2015 | Cancelled | Generating Revenue |
S1 Biopharma Comparisons
Industry
Financing
Details
S1 Biopharma Competitors (33)
One of S1 Biopharma’s 33 competitors is Pharmacosmos, a Corporate Backed or Acquired company based in Holbaek, Denmark.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Pharmacosmos | Corporate Backed or Acquired | Holbaek, Denmark | ||||
| Voyager Therapeutics | Formerly VC-backed | Lexington, MA | ||||
| NeRRe Therapeutics | Venture Capital-Backed | Stevenage, United Kingdom | ||||
| Mereo Biopharma Group | Formerly VC-backed | London, United Kingdom | ||||
| Verona Pharma | Corporate Backed or Acquired | London, United Kingdom |
S1 Biopharma Patents
S1 Biopharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025245066-A1 | Compositions and methods for affecting weight loss, weight management, sexual disorders, well-being, self-esteem, and/or self-confidence | Pending | 21-May-2024 | ||
| WO-2025245102-A2 | Methods and compositions for treating sexual disorder, weight loss, weight maintenance, well-being, and self-esteem | Pending | 21-May-2024 | ||
| WO-2025245102-A3 | Methods and compositions for treating sexual disorder, weight loss, weight maintenance, well-being, and self-esteem | Pending | 21-May-2024 | ||
| AU-2016204151-A1 | Methods of treating women for hypoactive sexual desire disorder (hsdd) with bupropion and trazodone combination treatment | Inactive | 17-Jun-2016 | ||
| CA-2933921-A1 | Methods of treating women for hypoactive sexual desire disorder (hsdd) with bupropion and trazodone combination treatment | Inactive | 17-Jun-2016 | A61K31/137 |
S1 Biopharma Signals
S1 Biopharma FAQs
-
When was S1 Biopharma founded?
S1 Biopharma was founded in 2008.
-
Where is S1 Biopharma headquartered?
S1 Biopharma is headquartered in New York, NY.
-
What is the size of S1 Biopharma?
S1 Biopharma has 4 total employees.
-
What industry is S1 Biopharma in?
S1 Biopharma’s primary industry is Drug Discovery.
-
Is S1 Biopharma a private or public company?
S1 Biopharma is a Private company.
-
What is S1 Biopharma’s current revenue?
The current revenue for S1 Biopharma is .
-
How much funding has S1 Biopharma raised over time?
S1 Biopharma has raised $15M.
-
Who are S1 Biopharma’s competitors?
Pharmacosmos, Voyager Therapeutics, NeRRe Therapeutics, Mereo Biopharma Group, and Verona Pharma are some of the 33 competitors of S1 Biopharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process